Abstract
This paper presents the clinical and pathological data obtained from 42 patients with oligodendroglioma diagnosed over a 20 year period at Addenbrooke's Hospital, Cambridge. In all cases the diagnosis was established unequivocally by histological examination. The principal conclusions of this study were: (1) the outcome was not as favourable as anticipated, nine patients dying within 1 year of diagnosis, and only 10 patients surviving 5 years, (2) age at the time of diagnosis was the single most important prognostic factor, patients under 45 years at diagnosis having a significantly greater survival time than older patients, (3) two other factors had a significantly adverse effect on prognosis, namely the presence of a focal neurological deficit at the time of diagnosis and the presence of nuclear pleomorphism in the tumour when examined histologically, (4) although cells containing glial fibrillary acidic protein were demonstrated in almost every tumour, their number and distribution did not appear to influence the prognosis.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burger P. C., Vollmer R. T. Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer. 1980 Sep 1;46(5):1179–1186. doi: 10.1002/1097-0142(19800901)46:5<1179::aid-cncr2820460517>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Chin H. W., Hazel J. J., Kim T. H., Webster J. H. Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas. Cancer. 1980 Mar 15;45(6):1458–1466. doi: 10.1002/1097-0142(19800315)45:6<1458::aid-cncr2820450627>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Choi B. H., Kim R. C. Expression of glial fibrillary acidic protein in immature oligodendroglia. Science. 1984 Jan 27;223(4634):407–409. doi: 10.1126/science.6197755. [DOI] [PubMed] [Google Scholar]
- Herpers M. J., Budka H. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol. 1984;64(4):265–272. doi: 10.1007/BF00690392. [DOI] [PubMed] [Google Scholar]
- Reedy D. P., Bay J. W., Hahn J. F. Role of radiation therapy in the treatment of cerebral oligodendroglioma: an analysis of 57 cases and a literature review. Neurosurgery. 1983 Nov;13(5):499–503. doi: 10.1227/00006123-198311000-00003. [DOI] [PubMed] [Google Scholar]
- Roberts M., German W. J. A long term study of patients with oligodendrogliomas. Follow-up of 50 cases, including Dr. Harvey Cushing's series. J Neurosurg. 1966 Apr;24(4):697–700. doi: 10.3171/jns.1966.24.4.0697. [DOI] [PubMed] [Google Scholar]
- Smith M. T., Ludwig C. L., Godfrey A. D., Armbrustmacher V. W. Grading of oligodendrogliomas. Cancer. 1983 Dec 1;52(11):2107–2114. doi: 10.1002/1097-0142(19831201)52:11<2107::aid-cncr2820521123>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]